NFKB1 and neoplasm: Downstream nuclear targets of cellular pathways, e.g., chromatin remodelers (EZH2), transcriptional factors (Myc and NF-κB), and cell cycle effectors (cyclins), are upregulated in cancer and also act as pro-oncogenic in tumor onset (Figure 1).